The aim of this study was observe molecular interactions human neutral α-glucosidase C (GANC_HUMAN) inhibition by cinnamate derivatives.  In this paper was used 50 cinnamate derivatives against a target macromolecule human neutral α-glucosidase C. We have been able to identify 13  α-glucosidase inhibitors by means of a computer-aided drug design protocol involving homology modelling of the target protein and the virtual screening with docking simulations in the binding free energy function. The model of enzyme was constructed based on crystal structure of the S. solphataricus α-glucosidase Ma1A and human N-terminal subunit of Maltase-Glucoamylase (NtMGAM) using software Autodock 4.2. Reference compounds in this simulation were 1-deoxynorijimycin, miglitol and acarbose and voglibose.

Keywords: Docking, α-glucosidase inhibitors, cinnamate derivatives, molecular simulation, human neutral α-glucosidase C, virtual screening